Validation of quantitative prognostic prediction using ADV score for resection of hepatocellular carcinoma : A Korea-Japan collaborative study with 9200 patients
© 2023 Japanese Society of Hepato-Biliary-Pancreatic Surgery..
BACKGROUND: A score derived from the concentrations of α-fetoprotein (AFP) and des-γ-carboxy prothrombin (DCP) and tumor volume (TV), called ADV score, has been shown to be prognostic of hepatocellular carcinoma (HCC) recurrence following hepatic resection (HR) or liver transplantation.
METHODS: This multicenter, multinational validation study included 9200 patients who underwent HR from 2010 to 2017 at 10 Korean and 73 Japanese centers, and were followed up until 2020.
RESULTS: AFP, DCP, and TV showed weak correlations (ρ ≤ .463, r ≤ .189, p < .001). Disease-free survival (DFS), overall survival (OS), and post-recurrence survival rates were dependent on 1.0 log and 2.0 log intervals of ADV scores (p < .001). Receiver operating characteristic (ROC) curve analysis showed that ADV score cutoffs of 5.0 log for DFS and OS yielded the areas under the curve ≥ .577, with both being significantly prognostic of tumor recurrence and patient mortality at 3 years. ADV score cutoffs of ADV 4.0 log and 8.0 log, derived through K-adaptive partitioning method, showed higher prognostic contrasts in DFS and OS. ROC curve analysis showed that an ADV score cutoff of 4.2 log was suggestive of microvascular invasion, with both microvascular invasion and an ADV score cutoff of 4.2 log showing similar DFS rates.
CONCLUSIONS: This international validation study demonstrated that ADV score is an integrated surrogate biomarker for post-resection prognosis of HCC. Prognostic prediction using ADV score can provide reliable information that can assist in planning treatment of patients with different stages of HCC and guide individualized post-resection follow-up based on the relative risk of HCC recurrence.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:30 |
|---|---|
| Enthalten in: |
Journal of hepato-biliary-pancreatic sciences - 30(2023), 8 vom: 20. Aug., Seite 993-1005 |
| Sprache: |
Englisch |
|---|
| Links: |
|---|
| Themen: |
Alpha-Fetoproteins |
|---|
| Anmerkungen: |
Date Completed 28.08.2023 Date Revised 28.08.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1002/jhbp.1319 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM353145998 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM353145998 | ||
| 003 | DE-627 | ||
| 005 | 20231226055335.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/jhbp.1319 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1177.xml |
| 035 | |a (DE-627)NLM353145998 | ||
| 035 | |a (NLM)36808234 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Kang, Woo-Hyoung |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Validation of quantitative prognostic prediction using ADV score for resection of hepatocellular carcinoma |b A Korea-Japan collaborative study with 9200 patients |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 28.08.2023 | ||
| 500 | |a Date Revised 28.08.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2023 Japanese Society of Hepato-Biliary-Pancreatic Surgery. | ||
| 520 | |a BACKGROUND: A score derived from the concentrations of α-fetoprotein (AFP) and des-γ-carboxy prothrombin (DCP) and tumor volume (TV), called ADV score, has been shown to be prognostic of hepatocellular carcinoma (HCC) recurrence following hepatic resection (HR) or liver transplantation | ||
| 520 | |a METHODS: This multicenter, multinational validation study included 9200 patients who underwent HR from 2010 to 2017 at 10 Korean and 73 Japanese centers, and were followed up until 2020 | ||
| 520 | |a RESULTS: AFP, DCP, and TV showed weak correlations (ρ ≤ .463, r ≤ .189, p < .001). Disease-free survival (DFS), overall survival (OS), and post-recurrence survival rates were dependent on 1.0 log and 2.0 log intervals of ADV scores (p < .001). Receiver operating characteristic (ROC) curve analysis showed that ADV score cutoffs of 5.0 log for DFS and OS yielded the areas under the curve ≥ .577, with both being significantly prognostic of tumor recurrence and patient mortality at 3 years. ADV score cutoffs of ADV 4.0 log and 8.0 log, derived through K-adaptive partitioning method, showed higher prognostic contrasts in DFS and OS. ROC curve analysis showed that an ADV score cutoff of 4.2 log was suggestive of microvascular invasion, with both microvascular invasion and an ADV score cutoff of 4.2 log showing similar DFS rates | ||
| 520 | |a CONCLUSIONS: This international validation study demonstrated that ADV score is an integrated surrogate biomarker for post-resection prognosis of HCC. Prognostic prediction using ADV score can provide reliable information that can assist in planning treatment of patients with different stages of HCC and guide individualized post-resection follow-up based on the relative risk of HCC recurrence | ||
| 650 | 4 | |a Multicenter Study | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a hepatocellular carcinoma | |
| 650 | 4 | |a microvascular invasion | |
| 650 | 4 | |a recurrence | |
| 650 | 4 | |a resection | |
| 650 | 4 | |a tumor biology | |
| 650 | 7 | |a alpha-Fetoproteins |2 NLM | |
| 650 | 7 | |a Biomarkers |2 NLM | |
| 650 | 7 | |a Biomarkers, Tumor |2 NLM | |
| 700 | 1 | |a Hwang, Shin |e verfasserin |4 aut | |
| 700 | 1 | |a Kaibori, Masaki |e verfasserin |4 aut | |
| 700 | 1 | |a Kim, Jong Man |e verfasserin |4 aut | |
| 700 | 1 | |a Kim, Kyung Sik |e verfasserin |4 aut | |
| 700 | 1 | |a Kobayashi, Tsuyoshi |e verfasserin |4 aut | |
| 700 | 1 | |a Kayashima, Hiroto |e verfasserin |4 aut | |
| 700 | 1 | |a Koh, Yang Seok |e verfasserin |4 aut | |
| 700 | 1 | |a Kubota, Keiichi |e verfasserin |4 aut | |
| 700 | 1 | |a Mori, Akira |e verfasserin |4 aut | |
| 700 | 1 | |a Takeda, Yutaka |e verfasserin |4 aut | |
| 700 | 1 | |a Yun, Sung Su |e verfasserin |4 aut | |
| 700 | 1 | |a Matsui, Kousuke |e verfasserin |4 aut | |
| 700 | 1 | |a Toriguchi, Kan |e verfasserin |4 aut | |
| 700 | 1 | |a Nagano, Hiroaki |e verfasserin |4 aut | |
| 700 | 1 | |a Yoon, Myung Hee |e verfasserin |4 aut | |
| 700 | 1 | |a Soejima, Yuji |e verfasserin |4 aut | |
| 700 | 1 | |a Ariizumi, Shunichi |e verfasserin |4 aut | |
| 700 | 1 | |a Kim, Bum-Soo |e verfasserin |4 aut | |
| 700 | 1 | |a Park, Yohan |e verfasserin |4 aut | |
| 700 | 1 | |a Yu, Hee Chul |e verfasserin |4 aut | |
| 700 | 1 | |a Kim, Bong Wan |e verfasserin |4 aut | |
| 700 | 1 | |a Lee, Jung Bok |e verfasserin |4 aut | |
| 700 | 1 | |a Park, Sang-Jae |e verfasserin |4 aut | |
| 700 | 1 | |a Jang, Jin-Young |e verfasserin |4 aut | |
| 700 | 1 | |a Yamaue, Hiroki |e verfasserin |4 aut | |
| 700 | 1 | |a Nakamura, Masafumi |e verfasserin |4 aut | |
| 700 | 1 | |a Yamamoto, Masakazu |e verfasserin |4 aut | |
| 700 | 1 | |a Endo, Itaru |e verfasserin |4 aut | |
| 700 | 0 | |a Collaboration of Korean Association of Hepato-Biliary-Pancreatic Surgery |e verfasserin |4 aut | |
| 700 | 0 | |a Japanese Society of Hepato-Biliary-Pancreatic Surgery |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of hepato-biliary-pancreatic sciences |d 2010 |g 30(2023), 8 vom: 20. Aug., Seite 993-1005 |w (DE-627)NLM188044477 |x 1868-6982 |7 nnns |
| 773 | 1 | 8 | |g volume:30 |g year:2023 |g number:8 |g day:20 |g month:08 |g pages:993-1005 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/jhbp.1319 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 30 |j 2023 |e 8 |b 20 |c 08 |h 993-1005 | ||